1 completed, 1 not yet recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Not yet recruiting 1 |
Follow Phase II Clinical Trial: new trials by email Literature Review of Phase II Clinical Trial trials Research Report on Phase II Clinical Trial
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase II Study of the Combination of Subcutaneous Blinatumomab and Olverembatinib in Patients With Philadelphia Chromosome (ph)-Positive and/or BCR::ABL1 Positive Acute Lymphoblastic Leukemia (ALL) Blinatumomab, olverembatinib - Phase II Clinical Trial, Blinatumomab | Phase 2 | Not yet recruiting | M.D. Anderson Cancer Center | 60 | 2027-01-27 | 2026-10-07 |
| Nitroglycerin Plus Intracranial Radiotherapy for Brain Metastases in NSCLC Patients Whole-brain radiotherapy - Phase II Clinical Trial, Ninety-six Histologically Confirmed NSCLC Patients With BM | Phase 2 | Completed | Instituto Nacional de Cancerologia de Mexico | 96 | 2020-03-01 | 2020-04-22 |
Brain Neoplasms (1) · Hypoxia (1) · Lung Neoplasms (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Neoplasms (2) · Brain Diseases (1) · Central Nervous System Diseases (1) · Central Nervous System Neoplasms (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Leukemia (1) · Leukemia, Lymphoid (1) · Lung Diseases (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1)
blinatumomab (1) · olverembatinib (1)
Instituto Nacional de Cancerologia de Mexico (1) · M.D. Anderson Cancer Center (1)
Mexico (1) · United States (1)